LIGAND PHARMACEUTICALS INCORPORATED Operating Lease, Liability, Noncurrent
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Operating Lease, Liability, Noncurrent of $3.78 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-07
- 2026-06-30: Operating Lease, Liability, Noncurrent $3.78M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $3.99M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $4.20M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $4.42M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $3.78M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $3.99M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $4.20M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $4.42M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $4.63M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $3.56M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $5.82M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $6.27M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $6.42M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $5.19M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $5.75M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $5.83M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $10.99M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $11.18M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $10.34M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $34.89M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $27.09M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $16.76M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $2.26M 10-K · filed 2023-02-28 | $15.49M 10-K · filed 2022-02-28 |
| 2021-09-30 | $11.47M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $4.77M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $6.08M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $5.64M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $3.92M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $9.18M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $9.23M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $9.97M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $9.93M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $10.49M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $4.32M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |